Manufacturer's investigation conclusion: no specific pump-related issues or adverse events were reported.The patient was reportedly transplanted on (b)(6) 2021 after being designated as bridge to transplant (btt).It was reported via the patient outcome that the patient underwent a transplant on (b)(6) 2021.There were no alarms associated with this event.Privacy laws prohibit the customer from providing information regarding the case; however, it was later reported that the patient was bridge to transplant (btt).The account indicated that although the patient¿s pump, heartmate 3 left ventricular assist system (lvas) , serial number (b)(6), was explanted, it would not be returned for evaluation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) and heartmate 3 lvas patient handbook are currently available.No specific device-related issues or adverse events were reported; however, the heartmate 3 lvas ifu provides a list of adverse events that may be associated with the use of the heartmate 3 left ventricular assist system in section 1, ¿introduction¿.No further information was provided.The manufacturer is closing the file on this event.
|